Report Detail

Other Global Capsule-based Inhalers Sales Market Report 2021

  • RnM3491850
  • |
  • 15 June, 2021
  • |
  • Global
  • |
  • 136 Pages
  • |
  • QYResearch
  • |
  • Other

Capsule-based inhalers belong to the category of dry powder inhalers and work according to a simple two-step procedure. Capsules are punctured or opened by pressing the device buttons. Then, after inspiration, powder is absorbed into the lung pathway.

Market Analysis and Insights: Global Capsule-based Inhalers Market
The global Capsule-based Inhalers market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Capsule-based Inhalers Scope and Market Size
The global Capsule-based Inhalers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Capsule-based Inhalers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Gelatin Capsules
Hypromellose Capsules

Segment by Application
Asthma
COPD (Chronic Obstructive Pulmonary Disease)

The Capsule-based Inhalers market is analysed and market size information is provided by regions (countries). Segment by Application, the Capsule-based Inhalers market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment


1 Capsule-based Inhalers Market Overview

  • 1.1 Capsule-based Inhalers Product Scope
  • 1.2 Capsule-based Inhalers Segment by Type
    • 1.2.1 Global Capsule-based Inhalers Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Gelatin Capsules
    • 1.2.3 Hypromellose Capsules
  • 1.3 Capsule-based Inhalers Segment by Application
    • 1.3.1 Global Capsule-based Inhalers Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Asthma
    • 1.3.3 COPD (Chronic Obstructive Pulmonary Disease)
  • 1.4 Capsule-based Inhalers Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Capsule-based Inhalers Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Capsule-based Inhalers Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Capsule-based Inhalers Price Trends (2016-2027)

2 Capsule-based Inhalers Estimates and Forecasts by Region

  • 2.1 Global Capsule-based Inhalers Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Capsule-based Inhalers Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Capsule-based Inhalers Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Capsule-based Inhalers Revenue Market Share by Region (2016-2021)
  • 2.3 Global Capsule-based Inhalers Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Capsule-based Inhalers Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Capsule-based Inhalers Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Capsule-based Inhalers Estimates and Projections (2016-2027)
    • 2.4.2 Europe Capsule-based Inhalers Estimates and Projections (2016-2027)
    • 2.4.3 China Capsule-based Inhalers Estimates and Projections (2016-2027)
    • 2.4.4 Japan Capsule-based Inhalers Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Capsule-based Inhalers Estimates and Projections (2016-2027)
    • 2.4.6 India Capsule-based Inhalers Estimates and Projections (2016-2027)

3 Global Capsule-based Inhalers Competition Landscape by Players

  • 3.1 Global Top Capsule-based Inhalers Players by Sales (2016-2021)
  • 3.2 Global Top Capsule-based Inhalers Players by Revenue (2016-2021)
  • 3.3 Global Capsule-based Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Capsule-based Inhalers as of 2020)
  • 3.4 Global Capsule-based Inhalers Average Price by Company (2016-2021)
  • 3.5 Manufacturers Capsule-based Inhalers Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Capsule-based Inhalers Market Size by Type

  • 4.1 Global Capsule-based Inhalers Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Capsule-based Inhalers Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Capsule-based Inhalers Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Capsule-based Inhalers Price by Type (2016-2021)
  • 4.2 Global Capsule-based Inhalers Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Capsule-based Inhalers Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Capsule-based Inhalers Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Capsule-based Inhalers Price Forecast by Type (2022-2027)

5 Global Capsule-based Inhalers Market Size by Application

  • 5.1 Global Capsule-based Inhalers Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Capsule-based Inhalers Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Capsule-based Inhalers Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Capsule-based Inhalers Price by Application (2016-2021)
  • 5.2 Global Capsule-based Inhalers Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Capsule-based Inhalers Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Capsule-based Inhalers Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Capsule-based Inhalers Price Forecast by Application (2022-2027)

6 North America Capsule-based Inhalers Market Facts & Figures

  • 6.1 North America Capsule-based Inhalers Sales by Company
    • 6.1.1 North America Capsule-based Inhalers Sales by Company (2016-2021)
    • 6.1.2 North America Capsule-based Inhalers Revenue by Company (2016-2021)
  • 6.2 North America Capsule-based Inhalers Sales Breakdown by Type
    • 6.2.1 North America Capsule-based Inhalers Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Capsule-based Inhalers Sales Breakdown by Type (2022-2027)
  • 6.3 North America Capsule-based Inhalers Sales Breakdown by Application
    • 6.3.1 North America Capsule-based Inhalers Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Capsule-based Inhalers Sales Breakdown by Application (2022-2027)

7 Europe Capsule-based Inhalers Market Facts & Figures

  • 7.1 Europe Capsule-based Inhalers Sales by Company
    • 7.1.1 Europe Capsule-based Inhalers Sales by Company (2016-2021)
    • 7.1.2 Europe Capsule-based Inhalers Revenue by Company (2016-2021)
  • 7.2 Europe Capsule-based Inhalers Sales Breakdown by Type
    • 7.2.1 Europe Capsule-based Inhalers Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Capsule-based Inhalers Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Capsule-based Inhalers Sales Breakdown by Application
    • 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Capsule-based Inhalers Market Facts & Figures

  • 8.1 China Capsule-based Inhalers Sales by Company
    • 8.1.1 China Capsule-based Inhalers Sales by Company (2016-2021)
    • 8.1.2 China Capsule-based Inhalers Revenue by Company (2016-2021)
  • 8.2 China Capsule-based Inhalers Sales Breakdown by Type
    • 8.2.1 China Capsule-based Inhalers Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Capsule-based Inhalers Sales Breakdown by Type (2022-2027)
  • 8.3 China Capsule-based Inhalers Sales Breakdown by Application
    • 8.3.1 China 246 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 246 Sales Breakdown by Application (2022-2027)

9 Japan Capsule-based Inhalers Market Facts & Figures

  • 9.1 Japan Capsule-based Inhalers Sales by Company
    • 9.1.1 Japan Capsule-based Inhalers Sales by Company (2016-2021)
    • 9.1.2 Japan Capsule-based Inhalers Revenue by Company (2016-2021)
  • 9.2 Japan Capsule-based Inhalers Sales Breakdown by Type
    • 9.2.1 Japan Capsule-based Inhalers Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Capsule-based Inhalers Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Capsule-based Inhalers Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Capsule-based Inhalers Market Facts & Figures

  • 10.1 Southeast Asia Capsule-based Inhalers Sales by Company
    • 10.1.1 Southeast Asia Capsule-based Inhalers Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Capsule-based Inhalers Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Capsule-based Inhalers Sales Breakdown by Type
    • 10.2.1 Southeast Asia Capsule-based Inhalers Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Capsule-based Inhalers Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Capsule-based Inhalers Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Capsule-based Inhalers Market Facts & Figures

  • 11.1 India Capsule-based Inhalers Sales by Company
    • 11.1.1 India Capsule-based Inhalers Sales by Company (2016-2021)
    • 11.1.2 India Capsule-based Inhalers Revenue by Company (2016-2021)
  • 11.2 India Capsule-based Inhalers Sales Breakdown by Type
    • 11.2.1 India Capsule-based Inhalers Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Capsule-based Inhalers Sales Breakdown by Type (2022-2027)
  • 11.3 India Capsule-based Inhalers Sales Breakdown by Application
    • 11.3.1 India Capsule-based Inhalers Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Capsule-based Inhalers Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Capsule-based Inhalers Business

  • 12.1 Hovione
    • 12.1.1 Hovione Corporation Information
    • 12.1.2 Hovione Business Overview
    • 12.1.3 Hovione Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Hovione Capsule-based Inhalers Products Offered
    • 12.1.5 Hovione Recent Development
  • 12.2 Iconovo AB
    • 12.2.1 Iconovo AB Corporation Information
    • 12.2.2 Iconovo AB Business Overview
    • 12.2.3 Iconovo AB Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Iconovo AB Capsule-based Inhalers Products Offered
    • 12.2.5 Iconovo AB Recent Development
  • 12.3 Inbrija
    • 12.3.1 Inbrija Corporation Information
    • 12.3.2 Inbrija Business Overview
    • 12.3.3 Inbrija Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Inbrija Capsule-based Inhalers Products Offered
    • 12.3.5 Inbrija Recent Development
  • 12.4 Utibron Neohaler (Novartis AG)
    • 12.4.1 Utibron Neohaler (Novartis AG) Corporation Information
    • 12.4.2 Utibron Neohaler (Novartis AG) Business Overview
    • 12.4.3 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Products Offered
    • 12.4.5 Utibron Neohaler (Novartis AG) Recent Development
  • 12.5 Zibo Laixu Medical Equipment
    • 12.5.1 Zibo Laixu Medical Equipment Corporation Information
    • 12.5.2 Zibo Laixu Medical Equipment Business Overview
    • 12.5.3 Zibo Laixu Medical Equipment Capsule-based Inhalers Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Zibo Laixu Medical Equipment Capsule-based Inhalers Products Offered
    • 12.5.5 Zibo Laixu Medical Equipment Recent Development

...

    13 Capsule-based Inhalers Manufacturing Cost Analysis

    • 13.1 Capsule-based Inhalers Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Capsule-based Inhalers
    • 13.4 Capsule-based Inhalers Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Capsule-based Inhalers Distributors List
    • 14.3 Capsule-based Inhalers Customers

    15 Market Dynamics

    • 15.1 Capsule-based Inhalers Market Trends
    • 15.2 Capsule-based Inhalers Drivers
    • 15.3 Capsule-based Inhalers Market Challenges
    • 15.4 Capsule-based Inhalers Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      Summary:
      Get latest Market Research Reports on Capsule-based Inhalers . Industry analysis & Market Report on Capsule-based Inhalers is a syndicated market report, published as Global Capsule-based Inhalers Sales Market Report 2021. It is complete Research Study and Industry Analysis of Capsule-based Inhalers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,000.00
      $6,000.00
      $8,000.00
      3,188.00
      4,782.00
      6,376.00
      3,716.00
      5,574.00
      7,432.00
      611,720.00
      917,580.00
      1,223,440.00
      333,680.00
      500,520.00
      667,360.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report